» Articles » PMID: 26240621

A Prospective Evaluation of the Influence of Three Bariatric Procedures on Insulin Resistance Improvement. Should the Extent of Undiluted Bile Transit Be Considered a Key Postoperative Factor Altering Glucose Metabolism?

Overview
Publisher Termedia
Date 2015 Aug 5
PMID 26240621
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Insulin resistance (IR), the essential step in development of type 2 diabetes mellitus (T2DM), resolves quickly after bariatric surgery, but the effectiveness depends on the type of the procedure. Although the long-term influence on IR improvement is well documented, the mechanisms of the ultra-fast response after restrictive and bypass procedures require explanation.

Aim: To determine IR evolution from the initial preparative period to 6 months after the operation, exposing the rapid postoperative response while comparing the 3 bariatric methods, with the belief that the metabolic effect may be correlated with anatomical combinations.

Material And Methods: From January to December, 2013, a cohort of severely obese, insulin resistant individuals recruited to the prospective study underwent laparoscopic sleeve gastrectomy (SG-30), Roux-en-Y gastric bypass (RYGB-30) and one-anastomosis gastric bypass (OAGB-30). Main laboratory parameters of glucose metabolism were evaluated in fasting patients preoperatively, 4 days and 1, 3 and 6 months after surgery.

Results: Within the whole observation period the most significant improvement in homeostasis model assessment for IR (HOMA-IR) was observed in the first 4 days after each operation. The decrease of HOMA-IR was higher (p < 0.0001) in gastric bypass groups than in patients after SG (-41%). The difference between bypass groups favors OAGB over RYGB (63 vs. -56%, p = 0.0489).

Conclusions: Among all bariatric management factors, operation type is the most important in IR improvement. The significant difference in response after SG vs. RYGB and OAGB supports the concept of metabolic competence of duodeno-jejunal exclusion. Altered bile flow after duodeno-jejunal exclusion may be responsible for enhanced glucose metabolism improvement.

Citing Articles

Serum free fatty acid levels and insulin resistance in patients undergoing one-anastomosis gastric bypass.

Liakh I, Proczko-Stepaniak M, Sledzinski M, Mika A Wideochir Inne Tech Maloinwazyjne. 2022; 17(1):194-198.

PMID: 35251406 PMC: 8886475. DOI: 10.5114/wiitm.2021.107754.


Fasting and postprandial acyl and desacyl ghrelin and the acyl/desacyl ratio in obese patients before and after different types of bariatric surgery.

Dardzinska J, Kaska L, Proczko-Stepaniak M, Szymanska-Gnacinska M, Aleksandrowicz-Wrona E, Malgorzewicz S Wideochir Inne Tech Maloinwazyjne. 2018; 13(3):366-375.

PMID: 30302150 PMC: 6174170. DOI: 10.5114/wiitm.2018.75868.


Evidence That the Length of Bile Loop Determines Serum Bile Acid Concentration and Glycemic Control After Bariatric Surgery.

Mika A, Kaska L, Proczko-Stepaniak M, Chomiczewska A, Swierczynski J, Smolenski R Obes Surg. 2018; 28(11):3405-3414.

PMID: 29790128 DOI: 10.1007/s11695-018-3314-9.


Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB)-IFSO Position Statement.

De Luca M, Tie T, Ooi G, Higa K, Himpens J, Carbajo M Obes Surg. 2018; 28(5):1188-1206.

PMID: 29600339 DOI: 10.1007/s11695-018-3182-3.


Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?.

Nora M, Morais T, Almeida R, Guimaraes M, Monteiro M Medicine (Baltimore). 2018; 96(48):e8859.

PMID: 29310367 PMC: 5728768. DOI: 10.1097/MD.0000000000008859.


References
1.
Halperin F, Ding S, Simonson D, Panosian J, Goebel-Fabbri A, Wewalka M . Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014; 149(7):716-26. PMC: 4274782. DOI: 10.1001/jamasurg.2014.514. View

2.
Cohen R, Pinheiro J, Schiavon C, Salles J, Wajchenberg B, Cummings D . Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012; 35(7):1420-8. PMC: 3379595. DOI: 10.2337/dc11-2289. View

3.
Salinari S, Bertuzzi A, Asnaghi S, Guidone C, Manco M, Mingrone G . First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2008; 32(3):375-80. PMC: 2646012. DOI: 10.2337/dc08-1314. View

4.
Gale E . GLP-1-based therapies and the exocrine pancreas: more light, or just more heat?. Diabetes. 2012; 61(5):986-8. PMC: 3331738. DOI: 10.2337/db11-1838. View

5.
Kaska L, Kobiela J, Proczko M, Stefaniak T, Sledzinski Z . Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients?. Wideochir Inne Tech Maloinwazyjne. 2014; 9(1):31-9. PMC: 3983547. DOI: 10.5114/wiitm.2014.40383. View